Amnis Granted Third U.S. Patent; Biotechnology Firm Developing Advanced Cell Analysis Platform.Business Editors & Health/Medical Writers BIOWIRE2K SEATTLE--(BUSINESS WIRE)--Dec. 10, 2002 Amnis Corporation, an emerging biotechnology company creating a next generation cell analysis platform, has announced the issuance of its third U.S. patent, number 6,473,176. The new patent, in conjunction with two previously-issued U.S. patents (6,249,341 and 6,211,955), covers the basic architecture of the Company's ImageStream(TM) technology for high throughput The speed with which a computer processes data. It is a combination of internal processing speed, peripheral speeds (I/O) and the efficiency of the operating system and other system software all working together. 1. cell imaging. "The broad claims and rapid issuance of these three patents are indicative of the great novelty Novelty is the quality of being new. Although it may be said to have an objective dimension (e.g. a new style of art coming into being, such as abstract art or impressionism) it essentially exists in the subjective perceptions of individuals. of Amnis' ImageStream(TM) platform and will help solidify so·lid·i·fy v. so·lid·i·fied, so·lid·i·fy·ing, so·lid·i·fies v.tr. 1. To make solid, compact, or hard. 2. To make strong or united. v.intr. Amnis' position at the forefront of high throughput cellular analysis," stated Harold Kawaguchi, chief executive officer of Amnis. In addition to the three granted patents, the Company has over 20 U.S patent applications allowed, pending, or in preparation, as well as corresponding international applications. About Amnis Headquartered in Seattle, Washington  This page is protected from moves until disputes have been resolved on the .The reason for its protection is listed on the protection policy page. , Amnis Corporation is developing ImageStream(TM), the next generation instrumentation instrumentation, in music: see orchestra and orchestration. instrumentation In technology, the development and use of precise measuring, analysis, and control equipment. platform, reagents, software, and services for high-throughput imaging and analysis of cells to advance basic research, drug discovery and development, and clinical diagnostics. Amnis is located at 2505 Third Avenue, Suite 210 Seattle, WA 98121 and can be reached by phone at 206/374-7000. |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion